Sep 05, 2019 / 02:20PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with The Cooper Companies. With us, we have Al White, President and CEO. In terms of the format, it's going to be a fireside chat. If anybody in the audience has a question they want to ask, please just raise your hand.
So Al, thanks for being with us.
Albert G. White - The Cooper Companies, Inc. - President, CEO & Director
Sure. Yes. Thanks for having me here.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior AnalystAll right. So Al, I wanted to start at a high level and then drill down in areas such as myopia management. I guess, maybe just start with the contact lens market. On the Q3 call, you said the market grew about 7% constant currency on a trailing 12-month basis, which is pretty strong. What's driving that